Taylor Wessing leverages its ‘broad industry knowledge’ to advise European and US life sciences clients on patent disputes across biotech, pharma and medical devices, with ’excellent UPC coordination’ capability. Co-practice head Alison Dennis leads the firm’s regulatory offering, ranging from medicine and device regulations to advertising, product safety, data protection, and competition. The firm also boasts transactional expertise, with co-head Andrew Edge being ‘highly trusted’ in M&A, IPOs, and private financing rounds. Nigel Stoate specialises in patent litigation and frequently coordinates multijurisdictional cases. Adrian Toutoungi and Charlie Adams are recognised for their ’deep expertise’ in pharmaceutical licensing and development agreements, supporting clients across a range of business models and objectives.
Legal 500 redaktioneller Kommentar
Auszeichnungen
Mandantenzufriedenheit: Abrechnung & Effizienz
Anwält*innen
Leading partners
Die stärksten Partner*innen ihres Praxisbereichs, die eine führende Rolle in signifikanten Mandaten einnehmen und weitreichende Anerkennung unter Wettbewerbern und Mandanten genießen.
Leading associates
Führende Associates sind regelmäßig an zentralen Mandaten des Teams beteiligt und erhalten positives Feedback von Wettbewerbern oder Mandanten.
Charlie Adams
Praxisleitung
Alison Dennis; Andrew Edge
Weitere Kernanwält*innen
Nigel Stoate; Adrian Toutoungi; Charlie Adams; Matt Royle; Andrew Payne; Mike Washbrook; Amanda Ebbutt